🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
Temsirolimus is a drug that is being studied to possibly treat kidney cance...
Status
Completed
Location
St. Joseph's Healthcare Hamilton
Start Date
2008-09
Trial ID
NCT01404104
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
This is an open label, single-center, randomized phase IV pilot study of st...
Status
Terminated
Location
Northwestern University/Northwestern Memorial Hospital
Start Date
2005-04
Trial ID
NCT00166712
Treatments Being Tested
The goal of this clinical research study is to learn if the combination of ...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2006-09
Trial ID
NCT00506948
Treatments Being Tested
This 2 x 2 sequential factorial study evaluates two potential improvements ...
Status
Completed
Location
Unversity of Nebraska Medical Center
Start Date
2004-04-01
Trial ID
NCT00556933
Primary Objective: 1\. To determine the maximally tolerated dose of anti-t...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2007-05
Trial ID
NCT00473551
Erlotinib and temsirolimus and may stop the growth of tumor cells by blocki...
Status
Completed
Location
University of California Los Angeles
Start Date
2005-04
Trial ID
NCT00112736
The objective of this study is to explore the effects of Sirolimus on the u...
Status
Recruiting
Location
University of Miami
Start Date
2021-10-27
Trial ID
NCT04141020
Treatments Being Tested